A look at COVID-19 vaccines already in use, or getting close
While a few have already hit the market, there are still dozens of coronavirus vaccines in development around the globe
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.While a few have already hit the market there are still dozens of coronavirus vaccines in development around the globe
Some use tried-and-true technologies, other use novel approaches. The shots were all tested differently, and some were allowed to go into use even before they were rigorously tested. How well they work varies, with preliminary study results ranging from 50% effective to over 90%.
So far, regulators in different countries have allowed use of about a half dozen, mostly under emergency use provisions. A few more are getting close. The ones available now all require two doses, given weeks apart.
Among those furthest along:
Pfizer: Developed with BioNTech; authorized by the U.S., U.K, European Union, the World Health Organization and elsewhere.
Moderna: Developed with the U.S. National Institutes of Health; authorized by the U.S., U.K., European Union, the World Health Organization and elsewhere.
AstraZeneca: Developed with Oxford University; authorized by more than 40 countries, including Britain, India, Argentina, Mexico and the European Union.
Sputnik V: Developed by Russia's Gamaleya Research Institute; authorized in Russia and about 10 other countries.
Sinopharm: Authorized in China and several countries including Hungary, Serbia, and Morocco.
Sinovac: Authorized in China as well as Turkey, Brazil and Indonesia.
Bharat Biotech: Authorized in India.
Johnson & Johnson: In development; one dose; expected to seek U.S. Food and Drug Administration authorization soon.
Novavax: In development.